Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease. 2017.07.26 Tweet Share 雑誌：Catheter Cardiovasc Interv. 2017 Jul;90(1):58-69. 著者：Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JMR, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R. Tweet Share Understanding the tricuspid valve for tr…前の記事 Cardiovascular magnetic resonance in an …次の記事
雑誌：Catheter Cardiovasc Interv. 2017 Jul;90(1):58-69. 著者：Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JMR, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R.
